BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33219287)

  • 1. Pivotal role of DPYSL2A in KLF4-mediated monocytic differentiation of acute myeloid leukemia cells.
    Noura M; Morita K; Kiyose H; Matsuo H; Nishinaka-Arai Y; Kurokawa M; Kamikubo Y; Adachi S
    Sci Rep; 2020 Nov; 10(1):20245. PubMed ID: 33219287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albendazole induces the terminal differentiation of acute myeloid leukaemia cells to monocytes by stimulating the Krüppel-like factor 4-dihydropyrimidinase-like 2A (KLF4-DPYSL2A) axis.
    Noura M; Morita K; Kiyose H; Okuno Y; Matsuo H; Koyama A; Nishinaka-Arai Y; Kamikubo Y; Adachi S
    Br J Haematol; 2021 Aug; 194(3):598-603. PubMed ID: 34227104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulated KLF4 Expression in Myeloid Leukemias Alters Cell Proliferation and Differentiation through MicroRNA and Gene Targets.
    Morris VA; Cummings CL; Korb B; Boaglio S; Oehler VG
    Mol Cell Biol; 2016 Feb; 36(4):559-73. PubMed ID: 26644403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kruppel-like factor 4 is essential for inflammatory monocyte differentiation in vivo.
    Alder JK; Georgantas RW; Hildreth RL; Kaplan IM; Morisot S; Yu X; McDevitt M; Civin CI
    J Immunol; 2008 Apr; 180(8):5645-52. PubMed ID: 18390749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RUNX1 inhibits proliferation and induces apoptosis of t(8;21) leukemia cells
    Liu S; Xing Y; Lu W; Li S; Tian Z; Xing H; Tang K; Xu Y; Rao Q; Wang M; Wang J
    Haematologica; 2019 Aug; 104(8):1597-1607. PubMed ID: 30792202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of the p53-KLF4-CEBPA Axis in Acute Myeloid Leukemia.
    Seipel K; Marques MT; Bozzini MA; Meinken C; Mueller BU; Pabst T
    Clin Cancer Res; 2016 Feb; 22(3):746-56. PubMed ID: 26408402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Kruppel-like factor KLF4 is a critical regulator of monocyte differentiation.
    Feinberg MW; Wara AK; Cao Z; Lebedeva MA; Rosenbauer F; Iwasaki H; Hirai H; Katz JP; Haspel RL; Gray S; Akashi K; Segre J; Kaestner KH; Tenen DG; Jain MK
    EMBO J; 2007 Sep; 26(18):4138-48. PubMed ID: 17762869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDAC1 and Klf4 interplay critically regulates human myeloid leukemia cell proliferation.
    Huang Y; Chen J; Lu C; Han J; Wang G; Song C; Zhu S; Wang C; Li G; Kang J; Wang J
    Cell Death Dis; 2014 Oct; 5(10):e1491. PubMed ID: 25341045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Krüppel-like factor 4 synergizes with CREB to increase the activity of apolipoprotein E gene promoter in macrophages.
    Stavri S; Simionescu M; Kardassis D; Gafencu AV
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):66-72. PubMed ID: 26546821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential role of the IRF8-KLF4 transcription factor cascade in murine monocyte differentiation.
    Kurotaki D; Osato N; Nishiyama A; Yamamoto M; Ban T; Sato H; Nakabayashi J; Umehara M; Miyake N; Matsumoto N; Nakazawa M; Ozato K; Tamura T
    Blood; 2013 Mar; 121(10):1839-49. PubMed ID: 23319570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling.
    Faber K; Bullinger L; Ragu C; Garding A; Mertens D; Miller C; Martin D; Walcher D; Döhner K; Döhner H; Claus R; Plass C; Sykes SM; Lane SW; Scholl C; Fröhling S
    J Clin Invest; 2013 Jan; 123(1):299-314. PubMed ID: 23202735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BAALC potentiates oncogenic ERK pathway through interactions with MEKK1 and KLF4.
    Morita K; Masamoto Y; Kataoka K; Koya J; Kagoya Y; Yashiroda H; Sato T; Murata S; Kurokawa M
    Leukemia; 2015 Nov; 29(11):2248-56. PubMed ID: 26050649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia.
    Germano G; Morello G; Aveic S; Pinazza M; Minuzzo S; Frasson C; Persano L; Bonvini P; Viola G; Bresolin S; Tregnago C; Paganin M; Pigazzi M; Indraccolo S; Basso G
    Oncotarget; 2017 Apr; 8(16):26129-26141. PubMed ID: 28412727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MYB proto-oncogene suppresses monocytic differentiation of acute myeloid leukemia cells via transcriptional activation of its target gene GFI1.
    Zhao L; Ye P; Gonda TJ
    Oncogene; 2014 Aug; 33(35):4442-9. PubMed ID: 24121275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydropyrimidinase-like 2 can serve as a novel therapeutic target and prognostic biomarker in acute myeloid leukemia.
    Li F; Ling Q; Lian J; Chen Y; Hu C; Yang M; Zhang X; Li C; Mao S; Ye W; Li X; Lin X; Wei W; Huang X; Pan J; Qian Y; Wang J; Lu Y; Jin J
    Cancer Med; 2023 Apr; 12(7):8319-8330. PubMed ID: 36621846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of a functional vitamin D receptor in all-trans-retinoic acid-induced monocytic differentiation of M2-type leukemic blast cells.
    Manfredini R; Trevisan F; Grande A; Tagliafico E; Montanari M; Lemoli R; Visani G; Tura S; Ferrari S; Ferrari S
    Cancer Res; 1999 Aug; 59(15):3803-11. PubMed ID: 10446999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Krüppel like factor 4 promoter undergoes active demethylation during monocyte/macrophage differentiation.
    Karpurapu M; Ranjan R; Deng J; Chung S; Lee YG; Xiao L; Nirujogi TS; Jacobson JR; Park GY; Christman JW
    PLoS One; 2014; 9(4):e93362. PubMed ID: 24695324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia.
    Khalife J; Radomska HS; Santhanam R; Huang X; Neviani P; Saultz J; Wang H; Wu YZ; Alachkar H; Anghelina M; Dorrance A; Curfman J; Bloomfield CD; Medeiros BC; Perrotti D; Lee LJ; Lee RJ; Caligiuri MA; Pichiorri F; Croce CM; Garzon R; Guzman ML; Mendler JH; Marcucci G
    Leukemia; 2015 Oct; 29(10):1981-92. PubMed ID: 25971362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The microRNA-26a target E2F7 sustains cell proliferation and inhibits monocytic differentiation of acute myeloid leukemia cells.
    Salvatori B; Iosue I; Mangiavacchi A; Loddo G; Padula F; Chiaretti S; Peragine N; Bozzoni I; Fazi F; Fatica A
    Cell Death Dis; 2012 Oct; 3(10):e413. PubMed ID: 23096114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parbendazole as a promising drug for inducing differentiation of acute myeloid leukemia cells with various subtypes.
    Matsuo H; Inagami A; Ito Y; Ito N; Iyoda S; Harata Y; Higashitani M; Shoji K; Tanaka M; Noura M; Mikami T; Kato I; Takita J; Nakahata T; Adachi S
    Commun Biol; 2024 Jan; 7(1):123. PubMed ID: 38267545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.